Medscape14h
Leqembi Okayed for Subset of Early Alzheimer’s Patients
The European Medicines Agency re-examined clinical data of a subset of patients with one or no copies of the APOE4 gene ...
PharmiWeb20h
Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease
Eisai Europe Ltd. and Biogen Inc. announced today that a positive opinion has been received from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) ...
Worldcrunch on MSN14h
Lecanemab: Why This Could Be The Beginning Of The End Of Alzheimer’s
The first drug targeting the root cause of Alzheimer’s disease has been approved by the European Medicines Agency. Despite ...
CBS 58 News5h
Former governor, HHS secretary Thompson on RFK Jr. appointment: 'Give him a chance'
Nearly 20 years after he stopped serving at the nation's top health official, Tommy Thompson on Friday said he supports President-elect Donald Trump's appointment of Robert F. Ke ...
Pharmaceutical Technology22h
Data Insights
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, ...